Tech Company Financing Transactions
Jennerex Biotherapeutics Funding Round
Jennerex Biotherapeutics, based in San Francisco, received $21.6 million from private investors.
Transaction Overview
Company Name
Announced On
5/23/2013
Transaction Type
Venture Equity
Amount
$21,600,000
Round
Undisclosed
Investors
Proceeds Purpose
This financing will enable us to expand our efforts to develop Pexa-Vec as a novel therapeutic option for liver cancer, our lead program, which represents the third most deadly cancer in the world.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
450 Sansome St. 16th Floor
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Website
Email Address
Overview
Jennerex Biotherapeutics, Inc. is a biotechnology company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eun-Sang Moon
Chief Financial Officer
Eun-Ki Min
Chief Operating Officer
Byung-Hak Kwak
Chief Technical Officer
Tae-Ho Hwang
VP - Operations
Georg Roth
Browse more venture capital transactions:
Prev: 5/23/2013: AlephCloud Systems venture capital transaction
Next: 5/23/2013: Lyft venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs